These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17451678)

  • 1. Effects of neuropeptide Y2 receptor blockade on ventricular arrhythmias in rats with acute myocardial infarction.
    Omerovic E; Råmunddal T; Lorentzon M; Nordlander M
    Eur J Pharmacol; 2007 Jun; 565(1-3):138-43. PubMed ID: 17451678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic effects of growth hormone--in vivo evidence from small-animal models of acute myocardial infarction and invasive electrophysiology.
    Råmunddal T; Gizurarson S; Lorentzon M; Omerovic E
    J Electrocardiol; 2008; 41(2):144-51. PubMed ID: 18328337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
    Tu B; Jiao Y; Herzog H; Nadler JV
    Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased mortality in a rat model of acute postinfarction heart failure.
    Råmunddal T; Lorentzon M; Omerovic E
    Biochem Biophys Res Commun; 2006 Mar; 341(2):459-63. PubMed ID: 16446154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of combined amiodarone and antiarrhythmic peptide use on the cardiac gap junctions and incidence of induced ventricular arrhythmias in healed myocardial infarction rabbit models].
    Li LD; Zhang CT; Ruan L; Ni MK; Fang Y; Wang GQ; Wang XF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1102-7. PubMed ID: 21215147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors.
    Wultsch T; Painsipp E; Thoeringer CK; Herzog H; Sperk G; Holzer P
    Neuroscience; 2005; 136(4):1097-107. PubMed ID: 16216428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular fibrillation induced by ischemia-reperfusion is not prevented by the NPY Y2 receptor antagonist BIIE0246.
    Ilebekk A; Eriksen M; Sevre K; Aspelin T; Björkman JA; Lyberg T; Nordlander M
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):177-83. PubMed ID: 17056830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esmolol activates endogenous neurokinin activity inhibiting infarction-induced arrhythmias in rats: novel mechanisms of anti-arrhythmia.
    Wang LL; Han Y; Guo Z; Han SQ; Liu T
    Regul Pept; 2013 Sep; 186():116-22. PubMed ID: 23994276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effects of myocardial creatine depletion on left ventricular function, morphology, and energy metabolism--consequences in acute myocardial infarction.
    Lorentzon M; Råmunddal T; Bollano E; Soussi B; Waagstein F; Omerovic E
    J Card Fail; 2007 Apr; 13(3):230-7. PubMed ID: 17448422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist.
    Doods H; Gaida W; Wieland HA; Dollinger H; Schnorrenberg G; Esser F; Engel W; Eberlein W; Rudolf K
    Eur J Pharmacol; 1999 Nov; 384(2-3):R3-5. PubMed ID: 10611450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diabetes mellitus and its treatment on ventricular arrhythmias complicating acute myocardial infarction.
    Rana JS; Mukamal KJ; Nesto RW; Morgan JP; Muller JE; Mittleman MA
    Diabet Med; 2005 May; 22(5):576-82. PubMed ID: 15842512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multicenter clinical trial on the prevention of sudden death after myocardial infarction by the use of anti-arrhythmia agents. Investigator Group of the Spanish Study on Sudden Death].
    Rev Esp Cardiol; 1989 Feb; 42(2):77-83. PubMed ID: 2675221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release.
    King PJ; Williams G; Doods H; Widdowson PS
    Eur J Pharmacol; 2000 May; 396(1):R1-3. PubMed ID: 10822055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved myocardial protection in the failing heart by selective endothelin-A receptor blockade.
    Trescher K; Bauer M; Dietl W; Hallström S; Wick N; Wolfsberger M; Ullrich R; Jürgens G; Wolner E; Podesser BK
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):1005-11, 1011e1. PubMed ID: 19327531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of acute vs. chronic oral amiodarone treatment during acute myocardial infarction in rats.
    Kolettis TM; Agelaki MG; Baltogiannis GG; Vlahos AP; Mourouzis I; Fotopoulos A; Pantos C
    Europace; 2007 Nov; 9(11):1099-104. PubMed ID: 17890289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the neuropeptide Y Y(2) receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices.
    Weiser T; Wieland HA; Doods HN
    Eur J Pharmacol; 2000 Sep; 404(1-2):133-6. PubMed ID: 10980271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats.
    He J; Chen Y; Huang Y; Yao F; Wu Z; Chen S; Wang L; Xiao P; Dai G; Meng R; Zhang C; Tang L; Huang Y; Li Z
    Eur J Pharmacol; 2009 Jan; 602(1):132-7. PubMed ID: 19027731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of propofol and sevoflurane on ischemia-induced ventricular arrhythmias and phosphorylated connexin 43 protein in rats.
    Hirata N; Kanaya N; Kamada N; Kimura S; Namiki A
    Anesthesiology; 2009 Jan; 110(1):50-7. PubMed ID: 19104170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.
    Abbate A; Salloum FN; Vecile E; Das A; Hoke NN; Straino S; Biondi-Zoccai GG; Houser JE; Qureshi IZ; Ownby ED; Gustini E; Biasucci LM; Severino A; Capogrossi MC; Vetrovec GW; Crea F; Baldi A; Kukreja RC; Dobrina A
    Circulation; 2008 May; 117(20):2670-83. PubMed ID: 18474815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of SM-20550 against myocardial infarction-induced arrhythmias, late infarct expansion, and left ventricular dysfunction.
    Grosjean N; Vié B; Létienne R; Le Grand B
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):563-70. PubMed ID: 18030067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.